(CNN) — Moderna announced a new agreement with the Gavi Vaccine Alliance to supply an additional 56.5 million doses of COVID-19 vaccine for delivery in the second quarter of 2022, the company said Friday.
This option of additional doses increases the agreement at the beginning of the year for 60 million doses of Moderna’s vaccine, bringing the total to 116.5 million doses of the COVID-19 vaccine.
92 low- and middle-income countries are covered by the agreement, according to a press release.
Gavi has the option to purchase an additional 233 million doses in 2022, the statement said. Doses are offered at the lowest price.
“I thank our partners at Gavi and Covax for their work and collaboration in reaching this agreement. This is another important milestone as we work to ensure that people around the world have access to our COVID-19 vaccine, ”Stéphane Bancel, Moderna’s CEO, said in the statement.
“We support Covax’s mission to ensure broad, affordable and equitable access to covid-19 vaccines and remain committed to doing everything we can to end this ongoing pandemic with our mRNA vaccine. We have recently offered Covax access to more vaccines for the second and third quarters of 2022. ”
–
